Fig. 1 · Structure

Documents & Downloads

PCC0208017

MARK3/MARK4 Inhibitor

PCC0208017 is a potent inhibitor of microtubule affinity regulating kinases MARK3 and MARK4, exhibiting IC50 values of 1.8 nM and 2.01 nM, respectively. The compound shows significantly reduced inhibition of MARK1 and MARK2, with IC50 values of 31.4 nM and 33.7 nM. PCC0208017 effectively suppresses glioma progression both in vitro and in vivo, disrupting microtubule dynamics and inducing G2/M phase cell cycle arrest and apoptosis. Additionally, it demonstrates considerable antitumor efficacy and favorable blood-brain barrier permeability.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 2623158-64-3
Applications MARK3/MARK4 Inhibitor
Formula C19H20F3N7
Molecular Weight 403.40
SMILES
FC(F)(C1=CN=C(NC2=CC=C3C(CCN(C3)C)=C2)N=C1NCC4=NNC=C4)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...